Keros Therapeutics, Inc. (KROS)
11.22
+0.24
(+2.19%)
USD |
NASDAQ |
May 21, 16:00
11.23
+0.01
(+0.09%)
After-Hours: 19:59
Keros Therapeutics Research and Development Expense (TTM) : 96.95M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Sarepta Therapeutics, Inc. | 896.74M |
| PTC Therapeutics, Inc. | 447.15M |
| Insmed, Inc. | 828.00M |
| United Therapeutics Corp. | 539.20M |
| Enanta Pharmaceuticals, Inc. | 91.32M |